PI3K‐Akt signaling pathway is a key driver in carcinogenesis and Akt overactivation has been verified in various endocrine gland neoplasms, including thyroid carcinoma subtypes, parathyroid carcinoma, pituitary tumor, and pheochromocytoma.34 This evidence concerns the gene AKT1 and endocrine gland neoplasm.